Alseres Pharmaceuticals Inc
Save
199.13K
Market cap
Current P/E
Forward P/E

About

Health care
Sector
Biotechnology
Industry

Alseres Pharmaceuticals, Inc. focuses on developing diagnostic and therapeutic products primarily for disorders in the central nervous system. Its lead product candidate is Altropane, a molecular imaging agent for the diagnosis of Parkinson's disease and dementia. The company was formerly known as Boston Life Sciences, Inc. and changed its name to Alseres Pharmaceuticals, Inc. in June 2007.

Similar securities

Based on sector and market capitalization

Report issue